Propella Acquisition To Shore Up Astellas’s Prostate Cancer Presence

Advantages Seen Over Zytiga

 
• By Ian Haydock
  
Astellas announced the acquisition of Propella for a $175m deal.
Propella deal to shore up Astellas's prostate cancer franchise • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Strategy

More from Business